According to Alkermes's latest financial reports the company's current earnings (TTM) are $0.44 B. an increase over its 2022 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.44 B | -388.18% |
2022 | -$0.16 B | 449.24% |
2021 | -$28.09 M | -68.04% |
2020 | -$87.88 M | -52.1% |
2019 | -$0.19 B | 64.49% |
2018 | -$0.12 B | -15.04% |
2017 | -$0.14 B | -34.2% |
2016 | -$0.2 B | -5.34% |
2015 | -$0.22 B | 35084.97% |
2014 | -$0.6 M | |
2012 | $7.42 M | -117.81% |
2011 | -$41.69 M | -12.69% |
2010 | -$47.74 M | 94.3% |
2009 | -$24.57 M | -117.7% |
2008 | $0.13 B | 622.63% |
2007 | $19.21 M | |
2004 | -$75.98 M | -14.48% |
2003 | -$88.84 M | 11.88% |
2002 | -$79.41 M | 39.65% |
2001 | -$56.86 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $21.36 B | 4,705.52% | ๐บ๐ธ USA |
Novartis NVS | $9.82 B | 2,110.55% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | 634.90% | ๐บ๐ธ USA |
Sanofi SNY | $7.26 B | 1,533.29% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | -$5.85 B | -1,415.03% | ๐บ๐ธ USA |
AstraZeneca AZN | $9.08 B | 1,942.74% | ๐ฌ๐ง UK |
Zogenix ZGNX | -$0.22 B | -147.70% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | -$0.27 B | -159.35% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.40 B | -8.90% | ๐ฎ๐ฑ Israel |